聚焦tRNA领域的Biotech倒闭
1月26日,一位投资者和一位...查看全文
牛唐2023-01-31 17:40
新年伊始,安进、辉瑞、默克、百时美施贵宝等大药企纷纷裁员,更有6家中小药企宣布破产,值此背景,哪些类型的医药公司有望获得市场青睐?
6家破产的中小药企:由Third rock、吉利德投资的肾病药物生公司Goldfinch Bio、从诺华分拆出来的抗生素公司Nabriva Therapeutics、从武田引入管线的Cali...查看全文
药时代2023-01-29 14:08
01 谁折去了金翅雀的翅膀?
2023年1月27日,一家名为Goldfinch Bio(金翅雀)的Biotech正在走ABCs破产程序。
(ABCs程序即一种新型破产程序,与清算不同的是:ABC清偿完毕债务人债权后,如有剩余现金,在不产生新债务的前提下受托人可以保持企业继续经营。与重组不同的是:在ABC程序中,有...查看全文
同写意2023-01-24 23:02
撰文丨Daisy
编辑丨于靖
如果要为过去一年选定医药行业关键词,裁员是绕不开的一个。
2022年,据Fierce Biotech统计,全球有超过100家医药企业宣布裁员。这波浪潮在11月达到顶峰,当月共有23家公司报告了裁员事件。而在国人求职的“金三银四”时节,裁员公司的数量也多达17家。
导...查看全文
SVB证券分析师Jonathan Chang将Calithera Biosciences(CALA)从增持下调至“与大市同步”,目标价从18美元下调至2美元。 此前该公司宣布mivavotinib和sapanisertib II期研究的初步数据预计将在2023年中期,这将超出2023年第二季度的现金流。... 网页链接
$Calithera Biosciences, Inc.(CALA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0000902664-18-000997 Size: 108 KB 网页链接
$Calithera Biosciences, Inc.(CALA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-08 AccNo: 0001645257-18-000003 Size: 18 KB 网页链接
$Calithera Biosciences, Inc.(CALA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-08 AccNo: 0000902219-18-000084 Size: 37 KB 网页链接
$Calithera Biosciences, Inc.(CALA)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-01 AccNo: 0000215457-18-004591 Size: 13 KB 网页链接
$Calithera Biosciences, Inc.(CALA)$ 8-K - Current report Filed: 2018-01-16 AccNo: 0001193125-18-011247 Size: 18 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http:...
$Calithera Biosciences, Inc.(CALA)$ 内部交易: 2017-12-05,SR. VP, DEVELOPMENT,Molineaux Christopher ,期权,9202普通股, $1.45
$Calithera Biosciences, Inc.(CALA)$ 内部交易: 2017-12-05,PRESIDENT AND CEO,Molineaux Susan ,期权,12868普通股, $1.65
$Calithera Biosciences, Inc.(CALA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-02 AccNo: 0001564590-17-021199 Size: 5 MB 网页链接
$Calithera Biosciences, Inc.(CALA)$ 8-K - Current report Filed: 2017-11-02 AccNo: 0001193125-17-330959 Size: 67 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Calithera Biosciences, Inc.(CALA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-02 AccNo: 0001564590-17-021199 Size: 5 MB 网页链接